Skip to main content

Table 2 Exosomal microRNA as diagnostic and prognostic biomarkers in HCC

From: Exosomal microRNAs in hepatocellular carcinoma

Exosomal microRNA as biomarkers

Biofluid

Clinical significance

References

exo-miR-215-5p

Serum

Overexpression predicts poor disease-free survival in patients with HCC

[117]

miR-10b-5p

Serum

Potential biomarker for early-stage HCC

[117]

miR-18a, miR-221, miR-222, miR-224, miR-101, miR-106b, miR-122, miR195

Serum

Novel serological biomarkers for HCC

[43]

miR-122, miR-148a and AFP

Serum

Distinguish early HCC from liver cirrhosis

[41]

miR-122

Serum

Distinguish HCC from normal control

[41]

miR-9-3p

Serum

A therapeutic target for HCC

[69]

miR-665

Serum

A novel minimally invasive biomarker for HCC diagnosis and prognosis

[70]

miR-21

Serum

A potential biomarker for HCC diagnosis.

[40]